You are on page 1of 15

India metals and mining

Sector outlook

Indrajit Agarwal 3Q21 preview - strong run continues


indrajit.agarwal@clsa.com Steel mills likely to report robust Ebitda/t increase, better 4Q outlook
+91 22 6650 5069
The steel price increase that started in June gained strength through 2HCY20. This
is likely to drive strong 3Q earnings increases despite soft volume growth. Higher
spot steel prices are likely to drive decade-high sector profitability in 4Q. Base
metal company earnings are also likely to improve on stronger prices. Overall we
expect 14-145% YoY Ebitda growth for covered steel/metal companies. Key issues
to watch are demand/volume outlook, capex guidance and leverage trajectory.
Tata Steel and Hindalco remain our top sector picks.
Steel - margins expected to improve on higher prices; 4Q likely to be decade-high
11 January 2021 q The steel price increase that started in June gained strength through 2HCY20, driven
by strong China demand, improving India demand, higher iron ore prices, and supply
India disruptions. This has led to a 21% (Rs6,050/t) QoQ spread increase.
q Domestic steel prices increased Rs7,200/t (18%) QoQ in 3Q. Spot steel prices are
Materials Rs10,000/t higher than the 3Q average (China export prices are up US$90/t). This will
drive decade-high margins for steel companies, in our view.
q India steel consumption has increased 6% YoY in the December quarter. Exports have
reduced meaningfully. Domestic steel exports have reduced from a run rate of 1.8mt
per month in the September quarter to 0.5mt in the December quarter.
q Tata Steel: India sales volumes have already been reported at down 4% YoY on a
strong 2Q and low inventory. Standalone profitability is likely to rise 35% QoQ to
Rs17,800. Profitability in Europe and outlook will be important (we expect up $18/t).
q Key things to watch are 1) an update on the Ijmuiden asset sale to SSAB, 2) net debt
trajectory, and 3) resumption of capex for Kalinganagar expansion.
q JSW Steel is also likely to report a sharp increase in standalone Ebitda/t to Rs14,000
(2Q: Rs10,136). Sales volumes are likely to decline YoY, similar to Tata Steel. Domestic
subsidiaries are likely to report strong results on high cold-rolled coil (CRC) spreads.
q Key things to watch include 1) an update on the Bhushan Power & Steel acquisition,
2) net debt trajectory, and 3) the FY22 volume outlook given Dolvi ramp-up expansion.
Hindalco - outlook on Novelis key
q Novelis: We expect profitability to remain strong at US$475/t (2Q: US$493/t) on
resilient spreads and improving auto sheet business. Volumes are likely to decline QoQ,
in line with seasonality.
q Domestic aluminium profitability is expected to rise US$51/t QoQ on higher aluminium
prices, partly offset by hedging and a higher cost of production (COP).
q Key things to watch include 1) outlook on Novelis recycling spreads, 2) auto sheet
demand trajectory, 3) domestic aluminium COP outlook, 4) hedges going into FY22,
and 5) an update on arbitration on Aleris’s Europe auto sheet business divestment.
Vedanta - non-operational issues remain in focus
q Earnings: We expect 38% YoY consolidated Ebitda growth to Rs72bn, mainly helped
by better commodity prices, while volumes are likely to remain stable.
q Vedanta’s parent recently announced an open offer to acquire 10% of the company at
Rs160/share (a 12% discount to the 8 January close), after acquiring a 5% stake recently.
q Key things to watch include 1) an update on the oil business production-sharing
contract (PSC), 2) FY22 capex, 3) key oil and zinc expansion project status, and 4) a
dividend announcement, if any.
q Focus remains on capital allocation issues at Vedanta (including inter-company loans)
and a stake increase by the parent company.
Coal India - volumes and margins expected to pick up
q Production and sales volume increases have already been reported at 6/9% YoY.
q We expect ASP to rise 1.5% QoQ (down 2.3% YoY) on better e-auction realisation as
the company has removed restrictions/ceiling on e-auction prices.
q On higher volumes, we expect cash cost/t ex-overburden removal (OBR) to fall 4%
YoY/13% QoQ and Ebitda/t ex-OBR to rise 2% YoY and PAT to rise 4% YoY to Rs41bn.
q Key issues to watch include a revised FY21 volume target (and FY22 outlook) and
capex outlook on the growth projects.
www.clsa.com
CLSA and CL Securities Taiwan Co., Ltd. (“CLST”) do and seek to do business with companies covered in its research reports. As such,
investors should be aware that there may be conflicts of interest which could affect the objectivity of the report. Investors should consider
this report as only a single factor in making their investment decisions. For important disclosures please refer to page 10.
 
 
3Q21 preview - strong run continues India metals and mining

Akshay Chandak (Strategy), Ayush Gandhi (Strategy), Mohit Gupta (Auto), Mononita Mitra (Materials) and Zen Javeri (Power, Infra and Capital Goods) provide
research support services to CLSA.

Figure 1

Ebitda of steel/metal stocks India metals and mining – 3QFY21 estimates (consolidated)
is likely to rise sharply JSW Steel Tata Steel Hindalco Vedanta Coal India
in 3Q YoY
Net revenue (Rsm) 209,121 398,463 321,329 225,811 247,005
Growth YoY 17% 12% 10% 12% 7%
Growth QoQ 10% 7% 3% 7% 17%

Ebitda (Rsm) 54,031 81,302 46,184 72,056 56,787


Growth YoY 145% 125% 38% 38% 14%
Growth QoQ 30% 23% (5%) 10% 43%

PAT (Rsm) 22,025 29,977 16,911 24,371 40,661


Growth YoY NM NM 62% 58% 4%
Growth QoQ 42% 62% 27% 212% 38%
Source: companies, CLSA. Note: We have not consolidated Aleris in our Hindalco estimates.

Tata Steel: In its 3Q production release, Tata Steel highlighted that exports were
11% of sales versus 24% in 2Q. Automotive and special products grew 48% YoY,
branded products & retail grew 5% YoY while industrial products & projects grew
47% YoY.

Figure 2

While volumes have been Tata Steel – key operational estimates


released already, margins Standalone 3QFY20 2QFY21 3QFY21E % QoQ % YoY
are likely to be very strong. Volumes - mt 3.4 3.6 3.3 (7) (3)
Pricing outlook for 4Q and ASP - Rs/t 44,524 45,524 51,053 12 15
profitability in Europe will Cash cost - Rs/t 33,503 32,657 33,288 2 (1)
be a key issue to watch. Ebitda - Rs/t 11,021 12,867 17,765 38 61
.
Europe 3QFY20 2QFY21 3QFY21E % QoQ % YoY
Volumes - mt 2.4 2.3 2.1 (7) (10)
ASP - US$/t 826 799 933 17 13
Cash cost - US$/t 883 799 915 15 4
Ebitda - US$/t (57) 1 18
.
Tata Steel BSL 3QFY20 2QFY21 3QFY21E % QoQ % YoY
Volumes - mt 1.3 1.3 1.2 (9) (8)
ASP - Rs/t 39,985 43,120 48,649 13 22
Cash cost - Rs/t 37,733 34,478 36,046 5 (4)
Ebitda - Rs/t 2,252 8,643 12,602 46 460
Source: companies, CLSA

JSW Steel: JSW had reported a domestic production increase of 2% YoY in 3Q.
Capacity utilisation was at 91% (2Q20: 86%). We expect domestic subsidiaries to
fare better on higher CRC prices.

Figure 3

Similar to Tata Steel, JSW Steel – key operational estimates


JSW is also likely to Per tonne economics 3QFY20 2QFY21 3QFY21CL QoQ (%) YoY (%)
show a sharp jump in Volumes (kt) 4,030 4,120 3,909 (5.1) (3.0)
profitability but a decline ASP/ton (Rs) 37,715 40,017 45,943 14.8 21.8
in sales volumes Cash costs/ton (Rs) 32,506 30,633 32,723 6.8 0.7
Ebitda/ton 5,998 10,136 14,014 38.3 133.7
Source: company, CLSA

Find CLSA research on Bloomberg, Thomson Reuters, FactSet and CapitalIQ - and profit from our evalu@tor proprietary database at clsa.com

11 January 2021 indrajit.agarwal@clsa.com 2


 
 
3Q21 preview - strong run continues India metals and mining

Figure 4

Domestic aluminium Hindalco – key operational estimates


profitability is likely to rise Aluminium 3QFY20 2QFY21 3QFY21CL YoY QoQ
on better aluminium prices, Sales volume – t 328,000 303,000 317,000 (3%) 5%
while COP is likely to rise Ebitda - Rsm (including Utkal) 9,640 10,660 12,359 28% 16%
Ebitda/t (US$) 414 469 520 26% 11%
Novelis profitability is likely Copper
to remain resilient Sales volume – t 84,000 75,000 75,000 (11%) 0%
Ebitda – Rsm 2,560 2,080 1,547 (40%) (26%)
Ebitda margin 5.4% 4.4% 3.2% (40%) (26%)
Novelis
Sales volume – t 797 923 877 10% (5%)
Ebitda - US$m 332 443 417 26% (6%)
Ebitda - US$/t 430 493 475 10% (4%)
Source: company, CLSA

Figure 5

Vedanta - key segment data


(Rsm) 3QFY20 2QFY21 3QFY21E % QoQ % YoY
HZL
Zinc production (kt) 178 180 180 - 1.1
Lead production (kt) 41 57 47 (17.5) 14.6
Silver production (t) 149 203 176 (13.4) 18.0
Ebitda 22,890 29,520 30,116 2.0 31.6
Zinc International
Production (kt) 60 51 55 7.8 (8.3)
Ebitda 1,060 2,610 3,338 NM 214.9
Oil
Gross op production (boepd) 172,189 165,045 165,045 - (4.1)
WI production (boepd) 110,656 102,216 102,216 - (7.6)
Ebitda 14,850 7,940 8,339 5.0 (43.8)
Aluminium
Ali production (kt) 483 472 471 (0.2) (2.5)
Ebitda 3,360 16,650 20,113 20.8 498.6
Iron Ore
Iron ore sales (mt of DMT) 1.7 1.5 1.7 14.1 -
Ebitda 2,140 2,560 3,466 35.4 62.0
Electrosteel Steels
Production (kt) 317 260 317 21.9 -
Ebitda 1,070 1,880 3,085 64.1 188.3
Power
Sales (m units) 2,282 3,998 3,998 - 75.2
Ebitda 3,790 4,710 4,710 - 24.3
Source: companies, CLSA

Figure 6

Vedanta - financial expectations summary


(Rsm) 3QFY20 2QFY21 3QFY21E % QoQ % YoY
Net sales 200,840 211,070 225,811 7.0 12.4
Ebitda 52,380 65,310 72,056 10.3 37.6
PBT 33,849 40,130 44,426 10.7 31.2
Profit after tax 26,650 16,440 31,098 89.2 16.7
Less: minority interest 3,170 8,240 6,727 (18.4) 112.2
Consolidated PAT 23,480 8,200 24,371 197.2 3.8
Source: company, CLSA

11 January 2021 indrajit.agarwal@clsa.com 3


 
 
3Q21 preview - strong run continues India metals and mining

Figure 7

E-auction prices are likely Coal India – key operational estimates


to rise from 2Q lows as Coal 3Q20 2Q21 3Q21E % QoQ % YoY
India removes restrictions Volumes - mt 142 134 154 15.3 9.0
on e-auction prices FSA 128 108 125 15.8 (1.9)
E-auction 10 22 25 11.8 155.1
Production and sales Others 4 3 4 21.1 1.6
volumes have already Volume mix (%)
been reported. FSA 90 81 81
E-auction 7 17 16
Others 3 3 3
Realisation - Rs/t 1,638 1,579 1,600 1.3 (2.3)
ASP ex other op income 1,523 1,454 1,474 1.3 (3.2)
FSA 1,411 1,412 1,412 0.0 0.1
E-auction 2,634 1,437 1,650 14.8 (37.4)

Cash cost - Rs/t 1,287 1,282 1,232 (3.9) (4.3)


Cash cost ex OBR - Rs/t 1,201 1,325 1,153 (13.0) (4.0)

Ebitda - Rs/t 351 297 368 24.0 4.8


Ebitda ex OBR - Rs/t 437 254 446 75.9 2.2
Source: company, CLSA

Figure 8

Steel production and Steel production and consumption growth


consumption have
improved 2/6% YoY in 3Q

Source: Centre for Monitoring Indian Economy

11 January 2021 indrajit.agarwal@clsa.com 4


 
 
3Q21 preview - strong run continues India metals and mining

Figure 9

Global iron ore prices have Iron ore price trajectory (indexed to April 2018)
strengthened much more
than domestic ore, which is
catching up now

Source: NMDC, Bloomberg

Figure 10

Domestic spreads have Indian steel prices and spreads trajectory


risen Rs6,000/t QoQ in 3Q
mainly because of price
hikes by Indian steelmakers
(3Q prices are Rs7,200/t
higher than the 2Q average)

Spot spreads have picked


up even more, driven by
higher steel prices
(Rs10,000/t higher
than the 3Q average).

Source: Bloomberg, CLSA

Figure 11

Globally, steel prices have Global steel price trajectory


picked up sharply
from 1Q lows, supporting
domestic steel prices

Source: Bloomberg

11 January 2021 indrajit.agarwal@clsa.com 5


 
 
3Q21 preview - strong run continues India metals and mining

Figure 12

The market cap of domestic China export hot-rolled coil prices versus indexed market cap of Indian steel companies*
steel companies has a
strong correlation with
China hot-rolled coil prices

Source: Bloomberg. *Tata Steel, JSW Steel, Steel Authority of India and Jindal Steel & Power.

Figure 13

Spreads are at multi-quarter Global steel spread trajectory


highs, supported by a sharp
increase in prices and lower
coking coal prices but
partly offset by higher
iron ore prices

Source: Bloomberg, CLSA

Figure 14

Coking coal prices have Global iron ore and coking coal prices (US$/t)
softened in the last few
weeks as China has banned
Australian coal

Source: Bloomberg, CLSA

11 January 2021 indrajit.agarwal@clsa.com 6


 
 
3Q21 preview - strong run continues India metals and mining

Figure 15

Domestic iron ore prices NMDC iron ore price trajectory


picked up meaningfully as
expected on lower
production from Odisha,
high exports and rising
steel production

Source: Bloomberg

Figure 16

Aluminium London Metal Aluminium, alumina price trajectory


Exchange is now up
about US$200/t
from the 2Q average

This augurs well for


Hindalco’s domestic
profitability

Source: Bloomberg, CLSA

Figure 17

The outlook for Scrap spreads versus Novelis profitability


Novelis’s profitability
will be key, given
softening scrap spreads

Source: Hindalco, Bloomberg

11 January 2021 indrajit.agarwal@clsa.com 7


 
 
3Q21 preview - strong run continues India metals and mining

Figure 18

Zinc and lead prices Zinc and lead price trajectories


continued to rally
from 1Q lows

Source: Bloomberg, CLSA

Figure 19

INR strength could lead to Exchange rate (USD-INR) trajectory


lower INR revenue for
base metal companies

Source: Bloomberg

Figure 20

Steel exports as a percent Exports as a percent of sales


of sales have continued
to decline

Source: companies

11 January 2021 indrajit.agarwal@clsa.com 8


 
 
3Q21 preview - strong run continues India metals and mining

Figure 21

Profitability of steel mills is Ebitda/t of steel companies


likely to rise sharply

Source: companies

11 January 2021 indrajit.agarwal@clsa.com 9


 
 
Important disclosures India metals and mining

Research subscriptions
To change your report distribution requirements, please contact your CLSA sales representative or email us at cib@clsa.com.
You can also fine-tune your Research Alert email preferences at https://www.clsa.com/member/tools/email_alert/.

Companies mentioned
Bhushan Power & Steel Ltd (N-R)
Coal India (COAL IS - RS141.7 - BUY)
Hindalco (HNDL IB - RS264.2 - BUY)
JSW Steel (JSTL IB - RS399.1 - SELL)
NDMC Ltd (N-R)
SSAB AB (N-R)
Tata Steel (TATA IB - RS695.5 - BUY)
Vedanta (VEDL IS - RS179.2 - O-PF)

Analyst certification
The analyst(s) of this report hereby certify that the views expressed in this research report accurately reflect my/our
own personal views about the securities and/or the issuers and that no part of my/our compensation was, is, or will
be directly or indirectly related to the specific recommendation or views contained in this research report.

Important disclosures
Recommendation history of Coal India Ltd COAL IS

Date Rec Target Date Rec Target


13 Nov 2020 BUY 140.00 29 Sep 2019 BUY 270.00
07 Sep 2020 BUY 155.00 31 May 2019 BUY 290.00
30 Jun 2020 BUY 160.00 13 Feb 2019 BUY 275.00
29 May 2020 BUY 170.00 02 Jan 2019 BUY 310.00
06 May 2020 BUY 185.00 31 May 2018 BUY 360.00
Source: CLSA

11 January 2021 indrajit.agarwal@clsa.com 10

 
 
Important disclosures India metals and mining

Recommendation history of Hindalco Industries Ltd HNDL IB

Date Rec Target Date Rec Target


14 Dec 2020 BUY 300.00 13 Feb 2019 SELL 195.00
11 Nov 2020 BUY 270.00 02 Jan 2019 SELL 210.00
24 Sep 2020 BUY 225.00 05 Nov 2018 U-PF 255.00
13 Aug 2020 BUY 230.00 13 Aug 2018 U-PF 225.00
15 Jun 2020 BUY 178.00 27 Jul 2018 U-PF 212.00
06 May 2020 BUY 160.00 18 May 2018 U-PF 245.00
12 Aug 2019 SELL 170.00 12 Mar 2018 SELL 205.00
08 Mar 2019 SELL 180.00 05 Feb 2018 O-PF 285.00
Source: CLSA

Recommendation history of JSW Steel Ltd JSTL IB

Date Rec Target Date Rec Target


07 Jan 2021 SELL 340.00 05 Sep 2019 SELL 170.00
14 Dec 2020 SELL 322.00 29 Jul 2019 SELL 200.00
26 Oct 2020 SELL 245.00 29 Jan 2019 SELL 225.00
29 Sep 2020 SELL 220.00 02 Jan 2019 SELL 260.00
10 Jun 2020 SELL 185.00 26 Oct 2018 U-PF 375.00
25 May 2020 U-PF 170.00 21 May 2018 BUY 410.00
06 May 2020 U-PF 166.00
Source: CLSA

11 January 2021 indrajit.agarwal@clsa.com 11

 
 
Important disclosures India metals and mining

Recommendation history of Tata Steel Ltd TATA IB

Date Rec Target Date Rec Target


07 Jan 2021 BUY 840.00 08 Nov 2019 SELL 295.00
14 Dec 2020 BUY 750.00 05 Sep 2019 SELL 275.00
17 Nov 2020 BUY 585.00 08 Aug 2019 SELL 320.00
29 Sep 2020 O-PF 405.00 11 Feb 2019 SELL 395.00
17 Aug 2020 SELL 340.00 29 Jan 2019 SELL 380.00
01 Jul 2020 SELL 285.00 02 Jan 2019 SELL 460.00
10 Jun 2020 SELL 304.00 02 Jul 2018 BUY 855.00
06 May 2020 U-PF 290.00 10 Feb 2018 BUY 920.00
Source: CLSA

Recommendation history of Vedanta Ltd VEDL IS

Date Rec Target Date Rec Target


07 Jan 2021 O-PF 173.00 29 Jul 2019 SELL 145.00
14 Dec 2020 O-PF 140.00 08 May 2019 SELL 135.00
09 Nov 2020 O-PF 100.00 01 Feb 2019 SELL 170.00
21 Oct 2020 O-PF 106.00 02 Jan 2019 BUY 250.00
12 Oct 2020 O-PF 118.00 02 Nov 2018 BUY 300.00
20 Aug 2020 O-PF 133.00 02 Aug 2018 BUY 330.00
22 Jul 2020 O-PF 105.00 04 May 2018 BUY 390.00
08 Jun 2020 O-PF 95.00 12 Mar 2018 BUY 410.00
06 May 2020 U-PF 80.00
Source: CLSA

11 January 2021 indrajit.agarwal@clsa.com 12

 
 
Important disclosures India metals and mining

The policy of CLSA and CL Securities Taiwan Co., Ltd. (“CLST”) is to - CLST: 15.49%, Restricted - CLST: 0.00%. Data as of 31 Dec 2020.
only publish research that is impartial, independent, clear, fair, and not Investment banking clients as a % of rating category: BUY /
misleading. Regulations or market practice of some Outperform - CLST: 0.00%, Underperform / SELL - CLST: 0.00%,
jurisdictions/markets prescribe certain disclosures to be made for Restricted - CLST: 0.00%. Data for 12-month period ending 31 Dec
certain actual, potential or perceived conflicts of interests relating to 2020.
a research report as below. This research disclosure should be read in There are no numbers for Hold/Neutral as CLSA/CLST do not
conjunction with the research disclaimer as set out at have such investment rankings. For a history of the recommendation,
www.clsa.com/disclaimer.html and the applicable regulation of the price targets and disclosure information for companies mentioned in
concerned market where the analyst is stationed and hence subject this report please write to: CLSA Group Compliance, 18/F, One Pacific
to. Investors are strongly encouraged to review this disclaimer before Place, 88 Queensway, Hong Kong and/or; (c) CLST Compliance (27/F,
investing. 95, Section 2 Dun Hua South Road, Taipei 10682, Taiwan, telephone
Neither analysts nor their household members/associates/may (886) 2 2326 8188). EVA® is a registered trademark of Stern, Stewart
have a financial interest in, or be an officer, director or advisory board & Co. "CL" in charts and tables stands for CLSA estimates, “CT” stands
member of companies covered by the analyst unless disclosed herein. for CLST estimates, "CRR" stands for CRR Research estimates and
In circumstances where an analyst has a pre-existing holding in any “CS” for Citic Securities estimates unless otherwise noted in the
securities under coverage, those holdings are grandfathered and the source.
analyst is prohibited from trading such securities. Charts and tables sourced to CLSA in this report may include data
Unless specified otherwise, CLSA/CLST or its respective affiliates, extracted from CLSA’s automated databases, which derive their
did not receive investment banking/non-investment banking income original data from a range of sources. These can include: companies;
from, and did not manage/co-manage a public offering for, the listed analyst estimates/calculations; local exchanges and/or third-party
company during the past 12 months, and it does not expect to receive data or market pricing providers such as Bloomberg, FactSet or IBES.
investment banking compensation from the listed company within the Additional information on data sources for specific charts or tables
coming three months. Unless mentioned otherwise, CLSA/CLST does can be obtained by contacting the publishing analysts.
not own 1% or more of any class of securities of the subject company, This publication/communication is subject to and incorporates
and does not make a market, in the securities. (For full disclosure of the terms and conditions of use set out on the www.clsa.com website
interest for all companies mention on this report, please refer to (https://www.clsa.com/disclaimer.html). Neither the
http://www.clsa.com/member/research_disclosures/ for details.) publication/communication nor any portion hereof may be reprinted,
The analysts included herein hereby confirm that they have not sold, resold, copied, reproduced, distributed, redistributed, published,
been placed under any undue influence, intervention or pressure by republished, displayed, posted or transmitted in any form or media or
any person/s in compiling this research report. In addition, the by any means without the written consent of CLSA and/or CLST.
analysts attest that they were not in possession of any material, non- CLSA and/or CLST has/have produced this
public information regarding the subject company at the time of publication/communication for private circulation to professional,
publication of the report. Save from the disclosure below (if any), the institutional and/or wholesale clients only, and may not be distributed
analyst(s) is/are not aware of any material conflict of interest. to retail investors. The information, opinions and estimates herein are
As analyst(s) of this report, I/we hereby certify that the views not directed at, or intended for distribution to or use by, any person
expressed in this research report accurately reflect my/our own or entity in any jurisdiction where doing so would be contrary to law
personal views about the securities and/or the issuers and that no or regulation or which would subject CLSA, and/or CLST to any
part of my/our compensation was, is, or will be directly or indirectly additional registration or licensing requirement within such
related to the specific recommendation or views contained in this jurisdiction. The information and statistical data herein have been
report or to any investment banking relationship with the subject obtained from sources we believe to be reliable. Such information has
company covered in this report (for the past one year) or otherwise not been independently verified and we make no representation or
any other relationship with such company which leads to receipt of warranty as to its accuracy, completeness or correctness. Any
fees from the company except in ordinary course of business of the opinions or estimates herein reflect the judgment of CLSA and/or
company. The analyst/s also state/s and confirm/s that he/she/they CLST at the date of this publication/communication and are subject
has/have not been placed under any undue influence, intervention or to change at any time without notice. Where any part of the
pressure by any person/s in compiling this research report. In information, opinions or estimates contained herein reflects the views
addition, the analysts included herein attest that they were not in and opinions of a sales person or a non-analyst, such views and
possession of any material, nonpublic information regarding the opinions may not correspond to the published view of CLSA and/or
subject company at the time of publication of the report. The analysts CLST. Any price target given in the report may be projected from one
further confirm that none of the information used in this report was or more valuation models and hence any price target may be subject
received from CLSA's Corporate Finance department or CLSA's Sales to the inherent risk of the selected model as well as other external
and Trading business. Save from the disclosure below (if any), the risk factors. Where the publication does not contain ratings, the
analyst(s) is/are not aware of any material conflict of interest. material should not be construed as research but is offered as factual
Key to CLSA/CLST investment rankings: BUY: Total stock return commentary. It is not intended to, nor should it be used to form an
(including dividends) expected to exceed 20%; O-PF: Total expected investment opinion about the non-rated companies.
return below 20% but exceeding market return; U-PF: Total expected This publication/communication is for information purposes only
return positive but below market return; SELL: Total return expected and it does not constitute or contain, and should not be considered as
to be negative. For relative performance, we benchmark the 12- an offer or invitation to sell, or any solicitation or invitation of any
month total forecast return (including dividends) for the stock against offer to subscribe for or purchase any securities in any jurisdiction
the 12-month forecast return (including dividends) for the market on and recipient of this publication/communication must make its own
which the stock trades. independent decisions regarding any securities or financial
"High Conviction" Ideas are not necessarily stocks with the most instruments mentioned herein. This is not intended to provide
upside/downside, but those where the Research Head/Strategist professional, investment or any other type of advice or
believes there is the highest likelihood of positive/negative returns. recommendation and does not take into account the particular
The list for each market is monitored weekly. investment objectives, financial situation or needs of individual
Overall rating distribution for CLSA (exclude CLST) only Universe: recipients. Before acting on any information in this
Overall rating distribution: BUY / Outperform - CLSA: 73.64%, publication/communication, you should consider whether it is
Underperform / SELL - CLSA: 26.28%, Restricted - CLSA: 0.34%; Data suitable for your particular circumstances and, if appropriate, seek
as of 31 Dec 2020. Investment banking clients as a % of rating professional advice, including tax advice. Investments involve risks,
category: BUY / Outperform - CLSA: 10.97%, Underperform / SELL - and investors should exercise prudence and their own judgment in
CLSA: 3.15%; Restricted - CLSA: 0.34%. Data for 12-month period making their investment decisions. The value of any investment or
ending 31 Dec 2020. income my go down as well as up, and investors may not get back the
Overall rating distribution for CLST only Universe: Overall rating full (or any) amount invested. Past performance is not necessarily a
distribution: BUY / Outperform - CLST: 84.51%, Underperform / SELL guide to future performance. CLSA and/or CLST do/does not accept

11 January 2021 indrajit.agarwal@clsa.com 13

 
 
Important disclosures India metals and mining

any responsibility and cannot be held liable for any person’s use of or Australia: CLSA Australia Pty Ltd (“CAPL”) (ABN 53 139 992
reliance on the information and opinions contained herein. To the 331/AFS License No: 350159) is regulated by ASIC and is a Market
extent permitted by applicable securities laws and regulations, CLSA Participant of ASX Limited and CHI-X. This material is issued and
and/or CLST accept(s) no liability whatsoever for any direct or distributed by CAPL in Australia to "wholesale clients" only. This
consequential loss arising from the use of this material does not take into account the specific investment
publication/communication or its contents. objectives, financial situation or particular needs of the recipient. The
To maintain the independence and integrity of our research, our recipient of this material must not distribute it to any third party
Corporate Finance, Sales Trading, Asset Management and Research without the prior written consent of CAPL. For the purposes of this
business lines are distinct from one another. This means that CLSA’s paragraph the term "wholesale client" has the meaning given in
Research department is not part of and does not report to CLSA section 761G of the Corporations Act 2001. CAPL’s research
Corporate Finance department or CLSA’s Sales and Trading business. coverage universe spans listed securities across the ASX All
Accordingly, neither the Corporate Finance nor the Sales and Trading Ordinaries index, securities listed on offshore markets, unlisted
department supervises or controls the activities of CLSA’s research issuers and investment products which Research management deem
analysts. CLSA’s research analysts report to the management of the to be relevant to the investor base from time to time. CAPL seeks to
Research department, who in turn report to CLSA’s senior cover companies of relevance to its domestic and international
management. CLSA has put in place a number of internal controls investor base across a variety of sectors.
designed to manage conflicts of interest that may arise as a result of India: CLSA India Private Limited, incorporated in November 1994
CLSA engaging in Corporate Finance, Sales and Trading, Asset provides equity brokerage services (SEBI Registration No:
Management and Research activities. Some examples of these INZ000001735), research services (SEBI Registration No:
controls include: the use of information barriers and other controls INH000001113) and merchant banking services (SEBI Registration
designed to ensure that confidential information is only shared on a No.INM000010619) to global institutional investors, pension funds
“need to know” basis and in compliance with CLSA’s Chinese Wall and corporates. CLSA and its associates may have debt holdings in the
policies and procedures; measures designed to ensure that subject company. Further, CLSA and its associates, in the past 12
interactions that may occur among CLSA’s Research personnel, months, may have received compensation for non-investment
Corporate Finance, Asset Management, and Sales and Trading banking securities and/or non-securities related services from the
personnel, CLSA’s financial product issuers and CLSA’s research subject company. For further details of “associates” of CLSA India
analysts do not compromise the integrity and independence of CLSA’s please contact Compliance-India@clsa.com.
research. Singapore: This report is distributed in Singapore by CLSA
Subject to any applicable laws and regulations at any given time, Singapore Pte Ltd to institutional investors, accredited investors or
CLSA, CLST, their respective affiliates, officers, directors or expert investors (each as defined under the Financial Advisers
employees may have used the information contained herein before Regulations) only. Singapore recipients should contact CLSA
publication and may have positions in, or may from time to time Singapore Pte Ltd, 80 Raffles Place, #18-01, UOB Plaza 1, Singapore
purchase or sell or have a material interest in any of the securities 048624, Tel: +65 6416 7888, in respect of any matters arising from,
mentioned or related securities, or may currently or in future have or or in connection with, the analysis or report. By virtue of your status
have had a business or financial relationship with, or may provide or as an institutional investor, accredited investor or expert investor,
have provided corporate finance/capital markets and/or other CLSA Singapore Pte Ltd is exempted from complying with certain
services to, the entities referred to herein, their advisors and/or any requirements under the Financial Advisers Act (Chapter 110), the
other connected parties. As a result, you should be aware that CLSA Financial Advisers Regulations and the relevant Notices and
and/or CLST and/or their respective affiliates, officers, directors or Guidelines issued thereunder (as disclosed in Part C of the Securities
employees may have one or more conflicts of interest. Regulations or Dealing Services – Singapore Annex of the CLSA terms of business),
market practice of some jurisdictions/markets prescribe certain in respect of any financial advisory services that CLSA Singapore Pte
disclosures to be made for certain actual, potential or perceived Ltd may provide to you. MCI (P) 024/12/2020
conflicts of interests relating to research reports. Details of the United States of America: Where any section is compiled by non-
disclosable interest can be found in certain reports as required by the US analyst(s), it is distributed into the United States by CLSA solely to
relevant rules and regulation and the full details are available at persons who qualify as "Major US Institutional Investors" as defined
http://www.clsa.com/member/research_disclosures/. Disclosures in Rule 15a-6 under the Securities and Exchange Act of 1934 and who
therein include the position of CLSA and CLST only. Unless specified deal with CLSA Americas. However, the delivery of this research
otherwise, CLSA did not receive any compensation or other benefits report to any person in the United States shall not be deemed a
from the subject company, covered in this recommendation to effect any transactions in the securities discussed
publication/communication, or from any third party. If investors have herein or an endorsement of any opinion expressed herein. Any
any difficulty accessing this website, please contact recipient of this research in the United States wishing to effect a
webadmin@clsa.com on +852 2600 8111. If you require disclosure transaction in any security mentioned herein should do so by
information on previous dates, please contact contacting CLSA Americas.
compliance_hk@clsa.com. The European Union (“EU”) and the United Kingdom: In these
This publication/communication is distributed for and on behalf jurisdictions, this research is a marketing communication. It has not
of CLSA (for research compiled by non-US and non-Taiwan analyst(s)), been prepared in accordance with the legal requirements designed to
and/or CLST (for research compiled by Taiwan analyst(s)) in Australia promote the independence of investment research, and is not subject
by CLSA Australia Pty Ltd (ABN 53 139 992 331/AFSL License No: to any prohibition on dealing ahead of the dissemination of
350159); in Hong Kong by CLSA Limited (Incorporated in Hong Kong investment research. The research is disseminated in these countries
with limited liability); in India by CLSA India Private Limited, (Address: by either CLSA (UK) or CLSA Europe BV. CLSA (UK) is authorised and
8/F, Dalamal House, Nariman Point, Mumbai 400021. Tel No: +91- regulated by the Financial Conduct Authority. CLSA Europe BV is
22-66505050. Fax No: +91-22-22840271; CIN: authorised and regulated by the Authority for Financial Markets in the
U67120MH1994PLC083118; SEBI Registration No: INZ000001735 Netherlands. This document is directed at persons having
as Stock Broker, INM000010619 as Merchant Banker and professional experience in matters relating to investments as defined
INH000001113 as Research Analyst,; in Indonesia by PT CLSA in the relevant applicable local regulations. Any investment activity to
Sekuritas Indonesia; in Japan by CLSA Securities Japan Co., Ltd.; in which it relates is only available to such persons. If you do not have
Korea by CLSA Securities Korea Ltd.; in Malaysia by CLSA Securities professional experience in matters relating to investments you should
Malaysia Sdn. Bhd.; in the Philippines by CLSA Philippines Inc (a not rely on this document. Where the research material is compiled
member of Philippine Stock Exchange and Securities Investors by the UK analyst(s), it is produced and disseminated by CLSA (UK)
Protection Fund); in Singapore by CLSA Singapore Pte Ltd and solely and CLSA Europe BV. For the purposes of the Financial Conduct Rules
to persons who qualify as an "Institutional Investor", "Accredited in the United Kingdom and MIFID II in other European jurisdictions
Investor" or "Expert Investor" MCI (P) 024/12/2020; in Thailand by this research is prepared and intended as substantive research
CLSA Securities (Thailand) Limited; in Taiwan by CLST and in the EU material.
and United Kingdom by CLSA Europe BV or CLSA (UK). For all other jurisdiction-specific disclaimers please refer to

11 January 2021 indrajit.agarwal@clsa.com 14

 
 
Important disclosures India metals and mining

https://www.clsa.com/disclaimer.html. The analysts/contributors to distributes the publication/communication in the respective


this publication/communication may be employed by any relevant jurisdictions.© 2021 CLSA and/or CL Securities Taiwan Co., Ltd.
CLSA entity or CLST, which is different from the entity that (“CLST”).

11 January 2021 indrajit.agarwal@clsa.com 15

 
 

You might also like